Parexel Early Phase Clinical Unitsupports the development of innovative new medicines which are vital for public health, improving outcomes, and saving lives. The early phase and "first in human" trials are the first step in testing these novel treatments in humans.
At Parexel's Glendale, CA unit ourhighly trained and skilled Research Associates are crucial to ensuring the successful completion of Phase I trials. This is a great role for anyone that aspires to be an enrollment specialist, clinical research coordinator, or eventually manager. Parexel provides a great system of support to help you grow and advance your career internally.
Your time here: As a Research Associateyou will constantly learn and be exposed to different parts of the early phase unit. The Research Associate works closely with nurses, clinical research coordinators, physicians, etc. to ensure the safety of volunteer participants by maintaining knowledge of study protocols, recruit, and interact with study participants and perform diagnostic laboratory tests.
Starting your journey with Parexel comes along with anextensive induction program and ongoing trainingwhile following your individual career path.
What you'll do after training is completed(including but not limited):
Your Skills
Your Profile:
Base Pay Range:$20.00 to $25.00 per hour
Actual salaries may vary within the range based on several factors including, but not limited to education, training, experience, professional achievement, and location.
In addition to base salary, some roles may be eligible for participation in Parexel's annual performance-based bonus plan, annual salary review and additional total rewards incentives.
Our talent acquisition team will provide additional details on our bonus plan or incentive programs for those eligible roles. For all eligible employees, we offer market leading benefit programs including paid time off, 401k match, life insurance, health insurance, and other benefit offerings in accordance with the terms of applicable plans.
Employment is contingent on disclosure of your COVID-19 vaccination status and, if relevant, proof of vaccination.